Biomarkers to Detect Endocrine Therapy Resistance — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Biomarkers to Detect Endocrine Therapy Resistance — Stella

Recruiting

Back to Metastatic Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

UW Carbone Cancer Center, Madison, Wisconsin

Key details

Phase

Safety & dosing

Sponsor

University of Wisconsin, Madison

Enrollment target

~8 participants

Started

April 2024

Primary completion

August 2026

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov